ArticleRSC advances2019
Effects of polyethylene glycol content on the properties of a silk fibroin/nano-hydroxyapatite/polyethylene glycol electrospun scaffold.
Article in RSC advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 12 citations in OpenAlex.
- How to Improve Physico-Chemical Properties of Silk Fibroin Materials for Biomedical Applications?-Blending and Cross-Linking of Silk Fibroin-A Review.Materials (Basel, Switzerland) · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To study the effects of polyethylene glycol (PEG) content on the mechanical properties and degradation of silk fibroin, nano-hydroxyapatite, and PEG (SF/nHAP/PEG) electrospun scaffolds, and according to the PEG ratio in the scaffold (SF : nHAP : PEG), test groups were divided as follows: PEG-0 (10 : 2), PEG-0.5 (10 : 2 : 0.5), PEG-1 (10 : 2 : 1), and PEG-2 (10 : 2 : 2). A series of tests to determine the mechanical properties, degradation rates, and osteogenic characteristics was undertaken. PEG facilitated SF degradation (PEG-1 > PEG-0.5 > PEG-0 > PEG-2), and the mass loss of the scaffolds in PEG-1 was more than 30%, while in PEG-2 it was less than 20% after 8 days (
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.